Hydroxyapatite Deposition Disease (HADD) is a crystal-induced tendinopathy caused by the deposition of hydroxyapatite (HA) crystals, typically in periarticular soft tissues, especially tendons and bursae. The shoulder (supraspinatus tendon) is most commonly affected. It often presents between ages 30–60, more frequently in women. While often asymptomatic, it can cause acute pain and functional limitation during resorptive phases.
Definition
Hydroxyapatite (HA): A calcium phosphate crystal naturally found in bone but pathologically deposited in soft tissues. HADD: Disease resulting from abnormal deposition of HA crystals in tendons or bursae, leading to pain and inflammation. Calcific tendinitis: Clinical term describing symptomatic HADD, often in the shoulder. Periarticular: Refers to structures surrounding a joint (e.g. tendons, bursae).
Anatomy and Physiology
The rotator cuff (supraspinatus, infraspinatus, subscapularis, teres minor) stabilizes the glenohumeral joint.
The subacromial-subdeltoid bursa reduces friction between the rotator cuff and overlying structures.
Tendons are poorly vascularized, especially near insertion zones (enthesis), which may predispose to crystal deposition.
Aetiology and Risk Factors
Aetiology
Unknown in most cases (idiopathic)
Possibly due to cell necrosis, hypoxia, or local mechanical stress causing crystal precipitation
May be related to disordered healing of tendon microtears
Risk Factors
Age 30–60
Female sex
Diabetes mellitus
Hypothyroidism
Repetitive overuse or trauma (especially shoulder)
Chronic renal disease (rare)
Remember
HADD = middle-aged women + shoulder pain + calcification.
Pathophysiology
Pre-calcific stage: Fibrocartilaginous metaplasia occurs in tendon → prone to mineralization
Calcific stage:
Formative phase: Deposition of HA crystals
Resorptive phase: Inflammatory reaction with macrophage and giant cell infiltration → severe pain
Post-calcific stage: Remodeling and healing with tendon reconstitution
Think
Symptoms typically arise in the resorptive phase due to intense local inflammation.
Clinical Manifestations
Often asymptomatic during formative phase
Acute calcific tendinitis
Sudden, severe shoulder pain, often nocturnal
Limited active ROM, especially abduction and external rotation
Pain on palpation over greater tuberosity
Chronic phase
Dull ache
Stiffness and impingement signs
Bursitis or tenosynovitis if crystals rupture into adjacent structures
Less common sites: hip, elbow, wrist, knee
Think
Shoulder pain + calcification on X-ray + intact ROM = HADD.
Diagnosis
No formal criteria, diagnosis is clinical + radiologic
X-ray
Homogeneous, dense calcific deposit in tendon (e.g. supraspinatus)
Location: 1–2 cm from insertion
Ultrasound
Hyperechoic calcification with posterior shadowing
May show signs of bursitis or tendon rupture
MRI
Shows soft tissue edema, inflammation, may mimic rotator cuff tear
Aspiration (rarely done)
HA crystals are non-birefringent, not visualized on polarised microscopy
Can stain with Alizarin red (calcium-binding dye)
Crystal Arthropathy Clinical Comparison Table
Feature
Gout
Pseudogout (CPPD)
BCP / Milwaukee Shoulder
HADD (Hydroxyapatite)
Typical Age
30–50 (M > F)
>60
>70 (F > M)
30–60 (F > M)
Crystal Type & Shape
Monosodium urate, needle
Calcium pyrophosphate, rhomboid
BCP (hydroxyapatite), amorphous
Hydroxyapatite, amorphous
Birefringence
Strongly negative
Weakly positive
None
None
Common Joint Involved
1st MTP, midfoot, ankle
Knee, wrist
Shoulder (glenohumeral joint)
Shoulder (supraspinatus tendon)
Synovial Fluid WBC
High (2,000–50,000+)
Moderate (2,000–50,000)
Low (<2,000), non-inflammatory
Normal to mildly elevated
Differential diagnoses
Rotator cuff tear
Subacromial bursitis
Adhesive capsulitis
Septic arthritis (if systemic signs present)
Gout/pseudogout (if intra-articular)
Remember
HADD calcific deposits are dense, homogeneous on X-ray and non-birefringent.
Remember
If unsure on ultrasound, confirm with X-ray – classic finding is curvilinear or oval dense calcification near tendon insertion.
Treatment
Acute phase
NSAIDs (first-line)
Rest and ice
Physiotherapy (after acute pain subsides)
Local corticosteroid injection if significant inflammation
Needle lavage/barbotage (ultrasound-guided): break up and aspirate calcification
Ultrasound therapy for pain control
Surgery (arthroscopic removal) if refractory after 6–12 months
Excellent prognosis in most with conservative management
Most resolve spontaneously within 1–3 weeks during resorptive phase
Poor Prognostic Factors
Large deposits
Chronic symptoms >6 months
Recurrent episodes
Poor compliance with rehab
References
Harvie P, Pollard TC, Carr AJ. Calcific tendinitis: natural history and association with endocrine disorders. J Shoulder Elbow Surg. 2007;16(2):169–173.
Uhthoff HK, Loehr JW. Calcific tendinopathy of the rotator cuff: pathogenesis, diagnosis, and management. J Am Acad Orthop Surg. 1997;5(4):183–191.
Chianca V, et al. Calcific tendinopathy: imaging findings and therapeutic options. Radiol Med. 2020;125(5):431–447.
Jiménez-Martín A, et al. Calcific tendinopathy of the shoulder: clinical and radiological analysis of 100 patients. Clin Rheumatol. 2022;41(3):821–828.
de Witte PB, et al. Therapeutic options for calcific tendinitis of the rotator cuff: a state-of-the-art review. Br J Sports Med. 2016;50(15):884–890.
Discussion